| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Apolipoproteins E | 12 | 2022 | 129 | 2.390 |
Why?
|
| Endothelial Cells | 9 | 2022 | 296 | 2.210 |
Why?
|
| Catalase | 16 | 2016 | 106 | 1.560 |
Why?
|
| Apolipoproteins B | 2 | 2022 | 18 | 1.550 |
Why?
|
| ATP-Binding Cassette Transporters | 5 | 2022 | 82 | 1.520 |
Why?
|
| Macrophages | 5 | 2016 | 431 | 1.240 |
Why?
|
| Lipoproteins, HDL | 3 | 2022 | 43 | 1.150 |
Why?
|
| Superoxide Dismutase | 15 | 2012 | 149 | 1.140 |
Why?
|
| Cholesterol | 10 | 2015 | 194 | 1.020 |
Why?
|
| Aorta | 17 | 2016 | 161 | 1.020 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2015 | 13 | 0.970 |
Why?
|
| Serine Endopeptidases | 2 | 2015 | 36 | 0.960 |
Why?
|
| Mice | 39 | 2022 | 5668 | 0.930 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2015 | 68 | 0.930 |
Why?
|
| Apolipoprotein A-I | 2 | 2022 | 21 | 0.910 |
Why?
|
| Endothelium, Vascular | 5 | 2018 | 229 | 0.840 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 338 | 0.800 |
Why?
|
| Sp1 Transcription Factor | 5 | 2012 | 44 | 0.760 |
Why?
|
| Atherosclerosis | 3 | 2015 | 131 | 0.710 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 968 | 0.680 |
Why?
|
| Lipoproteins | 2 | 2015 | 61 | 0.660 |
Why?
|
| Receptors, LDL | 3 | 2015 | 30 | 0.660 |
Why?
|
| Up-Regulation | 6 | 2014 | 490 | 0.660 |
Why?
|
| Animals | 44 | 2022 | 14307 | 0.660 |
Why?
|
| Signal Transduction | 7 | 2015 | 1802 | 0.620 |
Why?
|
| Aortic Diseases | 2 | 2009 | 26 | 0.600 |
Why?
|
| LDL-Receptor Related Proteins | 2 | 2015 | 9 | 0.560 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2016 | 245 | 0.560 |
Why?
|
| Response Elements | 2 | 2013 | 52 | 0.500 |
Why?
|
| Mice, Transgenic | 15 | 2016 | 608 | 0.480 |
Why?
|
| Mice, Knockout | 15 | 2014 | 897 | 0.470 |
Why?
|
| Antioxidants | 8 | 2009 | 386 | 0.440 |
Why?
|
| Lipoproteins, LDL | 6 | 2018 | 61 | 0.440 |
Why?
|
| Apolipoprotein E4 | 1 | 2012 | 47 | 0.430 |
Why?
|
| Glutathione Peroxidase | 7 | 2007 | 109 | 0.420 |
Why?
|
| Reactive Oxygen Species | 5 | 2009 | 416 | 0.390 |
Why?
|
| Cell Line | 5 | 2016 | 1289 | 0.380 |
Why?
|
| Hydrogen Peroxide | 7 | 2010 | 181 | 0.370 |
Why?
|
| Ketocholesterols | 2 | 2007 | 4 | 0.370 |
Why?
|
| Lysophosphatidylcholines | 2 | 2007 | 19 | 0.370 |
Why?
|
| Lipids | 5 | 2012 | 222 | 0.360 |
Why?
|
| Cells, Cultured | 11 | 2018 | 1442 | 0.340 |
Why?
|
| Foam Cells | 4 | 2012 | 13 | 0.340 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 550 | 0.330 |
Why?
|
| Arteriosclerosis | 3 | 2005 | 35 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 11 | 2016 | 1530 | 0.320 |
Why?
|
| Benzo(a)pyrene | 4 | 2016 | 122 | 0.320 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2004 | 27 | 0.310 |
Why?
|
| Receptors, Aryl Hydrocarbon | 4 | 2012 | 45 | 0.310 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2004 | 53 | 0.300 |
Why?
|
| Aging | 4 | 2004 | 639 | 0.290 |
Why?
|
| Cell Communication | 2 | 2004 | 93 | 0.280 |
Why?
|
| Cell Adhesion | 4 | 2009 | 209 | 0.270 |
Why?
|
| Oxidative Stress | 7 | 2013 | 874 | 0.260 |
Why?
|
| Caloric Restriction | 1 | 2004 | 29 | 0.240 |
Why?
|
| Cholecystokinin | 2 | 2014 | 15 | 0.240 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 161 | 0.240 |
Why?
|
| Cell Survival | 2 | 2006 | 818 | 0.240 |
Why?
|
| Lipid Peroxidation | 4 | 2009 | 131 | 0.230 |
Why?
|
| Phosphorylation | 5 | 2015 | 878 | 0.230 |
Why?
|
| Nitric Oxide | 2 | 2012 | 287 | 0.230 |
Why?
|
| Leukocytes | 1 | 2003 | 68 | 0.230 |
Why?
|
| Vasoconstrictor Agents | 1 | 2003 | 38 | 0.230 |
Why?
|
| Activin Receptors | 1 | 2022 | 2 | 0.220 |
Why?
|
| Caveolae | 1 | 2022 | 8 | 0.220 |
Why?
|
| Receptors, Scavenger | 1 | 2022 | 13 | 0.220 |
Why?
|
| Apolipoprotein E3 | 2 | 2012 | 10 | 0.220 |
Why?
|
| Coronary Vessels | 1 | 2022 | 93 | 0.210 |
Why?
|
| Humans | 14 | 2022 | 34853 | 0.210 |
Why?
|
| Apolipoprotein B-48 | 2 | 2013 | 7 | 0.210 |
Why?
|
| Protein Kinase C | 2 | 2012 | 110 | 0.200 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 200 | 0.200 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2012 | 73 | 0.190 |
Why?
|
| Ethanol | 2 | 2013 | 188 | 0.190 |
Why?
|
| Hypercholesterolemia | 2 | 2014 | 36 | 0.190 |
Why?
|
| Blotting, Western | 6 | 2012 | 834 | 0.180 |
Why?
|
| Running | 1 | 2019 | 13 | 0.180 |
Why?
|
| Cerebrovascular Circulation | 1 | 2019 | 71 | 0.180 |
Why?
|
| Blood Pressure | 1 | 2003 | 613 | 0.170 |
Why?
|
| Plicamycin | 3 | 2011 | 9 | 0.150 |
Why?
|
| Microsomes, Liver | 1 | 2016 | 69 | 0.140 |
Why?
|
| Calpain | 1 | 2016 | 31 | 0.140 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 115 | 0.140 |
Why?
|
| Monocytes | 2 | 2009 | 258 | 0.140 |
Why?
|
| Heterozygote | 4 | 2013 | 91 | 0.140 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 600 | 0.140 |
Why?
|
| Hepatic Stellate Cells | 2 | 2013 | 5 | 0.140 |
Why?
|
| Culture Media, Conditioned | 1 | 2015 | 44 | 0.140 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2015 | 7 | 0.140 |
Why?
|
| RNA, Messenger | 5 | 2013 | 1152 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 445 | 0.130 |
Why?
|
| Intestinal Absorption | 1 | 2014 | 19 | 0.120 |
Why?
|
| Triglycerides | 4 | 2012 | 129 | 0.120 |
Why?
|
| Models, Biological | 2 | 2019 | 642 | 0.120 |
Why?
|
| Binding Sites | 1 | 2015 | 597 | 0.120 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2013 | 2 | 0.120 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2013 | 4 | 0.120 |
Why?
|
| Hepatocytes | 1 | 2013 | 74 | 0.120 |
Why?
|
| Cholagogues and Choleretics | 1 | 2012 | 3 | 0.110 |
Why?
|
| Endocytosis | 1 | 2013 | 104 | 0.110 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2004 | 127 | 0.110 |
Why?
|
| Hypertriglyceridemia | 1 | 2012 | 13 | 0.110 |
Why?
|
| Central Nervous System Depressants | 1 | 2013 | 37 | 0.110 |
Why?
|
| Pylorus | 1 | 2012 | 4 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2004 | 224 | 0.110 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2011 | 14 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2012 | 51 | 0.110 |
Why?
|
| Male | 13 | 2019 | 18870 | 0.100 |
Why?
|
| Apoptosis | 3 | 2006 | 1317 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2011 | 423 | 0.100 |
Why?
|
| Disease Models, Animal | 4 | 2012 | 1300 | 0.100 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2011 | 12 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 2 | 2016 | 240 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2013 | 226 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 180 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2003 | 160 | 0.090 |
Why?
|
| Acceleration | 1 | 1989 | 5 | 0.090 |
Why?
|
| F2-Isoprostanes | 2 | 2009 | 20 | 0.090 |
Why?
|
| Chemical Warfare Agents | 1 | 2009 | 12 | 0.090 |
Why?
|
| G1 Phase | 1 | 2009 | 32 | 0.090 |
Why?
|
| Lung Injury | 1 | 2009 | 12 | 0.090 |
Why?
|
| S Phase | 1 | 2009 | 36 | 0.090 |
Why?
|
| Mustard Gas | 1 | 2009 | 31 | 0.090 |
Why?
|
| DNA Damage | 2 | 2001 | 341 | 0.090 |
Why?
|
| Myocardial Contraction | 1 | 1989 | 47 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 1 | 2009 | 70 | 0.080 |
Why?
|
| 2-Aminopurine | 1 | 2008 | 9 | 0.080 |
Why?
|
| Liposomes | 1 | 2009 | 107 | 0.080 |
Why?
|
| Macrophages, Peritoneal | 1 | 2008 | 22 | 0.080 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2008 | 18 | 0.080 |
Why?
|
| Caspases | 2 | 2006 | 132 | 0.080 |
Why?
|
| Hydrolases | 1 | 2007 | 14 | 0.080 |
Why?
|
| Lung | 2 | 2009 | 413 | 0.080 |
Why?
|
| Hypertension | 2 | 2006 | 770 | 0.080 |
Why?
|
| Heart Rate | 1 | 1989 | 248 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 109 | 0.080 |
Why?
|
| Bioprosthesis | 1 | 2007 | 5 | 0.080 |
Why?
|
| Bone Substitutes | 1 | 2007 | 3 | 0.080 |
Why?
|
| Skull Fractures | 1 | 2007 | 4 | 0.080 |
Why?
|
| Heart | 1 | 1989 | 178 | 0.080 |
Why?
|
| Lysosomes | 1 | 2007 | 80 | 0.080 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2007 | 22 | 0.070 |
Why?
|
| Anthozoa | 1 | 2007 | 24 | 0.070 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2006 | 9 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2007 | 54 | 0.070 |
Why?
|
| Cell Shape | 1 | 2006 | 35 | 0.070 |
Why?
|
| Necrosis | 1 | 2006 | 45 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2006 | 194 | 0.070 |
Why?
|
| Liver | 4 | 2005 | 447 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 183 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 180 | 0.070 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2004 | 4 | 0.070 |
Why?
|
| Enzyme Induction | 1 | 2004 | 48 | 0.060 |
Why?
|
| Free Radical Scavengers | 2 | 2009 | 65 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 286 | 0.060 |
Why?
|
| Free Radicals | 1 | 2003 | 72 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 184 | 0.060 |
Why?
|
| Cytochrome P-450 CYP1A1 | 2 | 2016 | 43 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 84 | 0.060 |
Why?
|
| Calcium | 1 | 2006 | 445 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 220 | 0.060 |
Why?
|
| Norepinephrine | 1 | 2003 | 107 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2019 | 123 | 0.050 |
Why?
|
| Angiotensin II | 1 | 2003 | 92 | 0.050 |
Why?
|
| Deoxyribonuclease (Pyrimidine Dimer) | 1 | 2001 | 2 | 0.050 |
Why?
|
| Gene Expression | 3 | 2015 | 639 | 0.050 |
Why?
|
| Oxidation-Reduction | 4 | 2007 | 407 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 522 | 0.050 |
Why?
|
| Mitochondria, Heart | 1 | 2001 | 66 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 391 | 0.050 |
Why?
|
| Escherichia coli Proteins | 1 | 2001 | 119 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 111 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 484 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 274 | 0.040 |
Why?
|
| Rabbits | 2 | 2007 | 278 | 0.040 |
Why?
|
| Computational Biology | 1 | 2019 | 275 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 1998 | 164 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2008 | 210 | 0.040 |
Why?
|
| Gastric Mucosa | 2 | 2012 | 50 | 0.040 |
Why?
|
| DNA Repair | 1 | 1998 | 181 | 0.040 |
Why?
|
| Xenobiotics | 1 | 2016 | 10 | 0.040 |
Why?
|
| Peroxides | 1 | 2016 | 20 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2016 | 72 | 0.040 |
Why?
|
| Time Factors | 3 | 2007 | 1681 | 0.040 |
Why?
|
| Age Factors | 1 | 2019 | 1007 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2016 | 101 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2015 | 53 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 175 | 0.030 |
Why?
|
| Receptor, Cholecystokinin B | 1 | 2014 | 9 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2014 | 11 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2014 | 48 | 0.030 |
Why?
|
| Intestines | 1 | 2014 | 63 | 0.030 |
Why?
|
| Chloroquine | 1 | 2013 | 19 | 0.030 |
Why?
|
| Endosomes | 1 | 2013 | 34 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2007 | 420 | 0.030 |
Why?
|
| Mutation | 2 | 2011 | 1023 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2007 | 649 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 88 | 0.030 |
Why?
|
| Superoxides | 2 | 2004 | 51 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 85 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 286 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2013 | 87 | 0.030 |
Why?
|
| Apolipoproteins | 1 | 2012 | 19 | 0.030 |
Why?
|
| Cytosol | 2 | 2004 | 85 | 0.030 |
Why?
|
| Alleles | 1 | 2013 | 284 | 0.030 |
Why?
|
| Transfection | 2 | 2008 | 496 | 0.030 |
Why?
|
| Nitrergic Neurons | 1 | 2012 | 5 | 0.030 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2012 | 9 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 32 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 984 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2012 | 35 | 0.030 |
Why?
|
| Stomach | 1 | 2012 | 43 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 87 | 0.030 |
Why?
|
| Random Allocation | 1 | 2012 | 139 | 0.030 |
Why?
|
| Mice, Inbred DBA | 2 | 2001 | 69 | 0.030 |
Why?
|
| Female | 5 | 2012 | 19873 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 528 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 555 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 79 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2014 | 486 | 0.020 |
Why?
|
| Rats, Inbred F344 | 2 | 2001 | 228 | 0.020 |
Why?
|
| Amitrole | 1 | 2009 | 4 | 0.020 |
Why?
|
| Glutathione | 2 | 2001 | 160 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2009 | 24 | 0.020 |
Why?
|
| Barbital | 1 | 1989 | 1 | 0.020 |
Why?
|
| Strophanthins | 1 | 1989 | 1 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 21 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2009 | 83 | 0.020 |
Why?
|
| Ventricular Function | 1 | 1989 | 8 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2009 | 49 | 0.020 |
Why?
|
| Furans | 1 | 2009 | 34 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 54 | 0.020 |
Why?
|
| Pressure | 1 | 1989 | 36 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2009 | 141 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 1989 | 177 | 0.020 |
Why?
|
| Myocardium | 2 | 2001 | 224 | 0.020 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2007 | 7 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 605 | 0.020 |
Why?
|
| Rats | 3 | 2001 | 3261 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 392 | 0.020 |
Why?
|
| Absorbable Implants | 1 | 2007 | 3 | 0.020 |
Why?
|
| Fracture Healing | 1 | 2007 | 3 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2007 | 7 | 0.020 |
Why?
|
| Implants, Experimental | 1 | 2007 | 5 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2007 | 10 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2007 | 31 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2007 | 57 | 0.020 |
Why?
|
| Skull | 1 | 2007 | 35 | 0.020 |
Why?
|
| Dinoprost | 1 | 2006 | 22 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2007 | 59 | 0.020 |
Why?
|
| Copper | 1 | 2006 | 101 | 0.020 |
Why?
|
| Ataxia Telangiectasia | 1 | 2005 | 6 | 0.020 |
Why?
|
| Diet | 2 | 2002 | 747 | 0.020 |
Why?
|
| Zinc | 1 | 2006 | 114 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 485 | 0.020 |
Why?
|
| Paraquat | 1 | 2004 | 20 | 0.020 |
Why?
|
| Gamma Rays | 1 | 2004 | 25 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2006 | 333 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 63 | 0.020 |
Why?
|
| Reperfusion Injury | 1 | 2004 | 53 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 93 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2004 | 53 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 97 | 0.020 |
Why?
|
| Models, Animal | 1 | 2004 | 131 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 94 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2003 | 32 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 122 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2004 | 72 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2009 | 1149 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 78 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 296 | 0.010 |
Why?
|
| Skin | 1 | 2004 | 173 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2004 | 252 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 404 | 0.010 |
Why?
|
| DNA-Formamidopyrimidine Glycosylase | 1 | 2001 | 2 | 0.010 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2001 | 6 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 641 | 0.010 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2001 | 5 | 0.010 |
Why?
|
| Aconitate Hydratase | 1 | 2001 | 7 | 0.010 |
Why?
|
| Sodium Iodide | 1 | 2001 | 3 | 0.010 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2001 | 10 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2001 | 34 | 0.010 |
Why?
|
| Food Deprivation | 1 | 2001 | 30 | 0.010 |
Why?
|
| Endodeoxyribonucleases | 1 | 2001 | 29 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2001 | 23 | 0.010 |
Why?
|
| Oxidants | 1 | 2001 | 43 | 0.010 |
Why?
|
| Permeability | 1 | 2001 | 67 | 0.010 |
Why?
|
| Comet Assay | 1 | 2001 | 72 | 0.010 |
Why?
|
| Deoxyguanosine | 1 | 2001 | 34 | 0.010 |
Why?
|
| Energy Intake | 1 | 2002 | 160 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2001 | 98 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2001 | 197 | 0.010 |
Why?
|
| Species Specificity | 1 | 2001 | 233 | 0.010 |
Why?
|
| Mitochondria | 1 | 2004 | 454 | 0.010 |
Why?
|
| Food | 1 | 2001 | 95 | 0.010 |
Why?
|
| Glutathione Disulfide | 1 | 1999 | 7 | 0.010 |
Why?
|
| Pyrimidine Dimers | 1 | 1998 | 3 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1998 | 42 | 0.010 |
Why?
|
| Albumins | 1 | 1998 | 24 | 0.010 |
Why?
|
| Spleen | 1 | 1999 | 192 | 0.010 |
Why?
|
| DNA | 1 | 2001 | 549 | 0.010 |
Why?
|
| ras Proteins | 1 | 1998 | 49 | 0.010 |
Why?
|
| Cats | 1 | 1998 | 65 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1998 | 116 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1998 | 132 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 257 | 0.010 |
Why?
|
| Kidney | 1 | 1999 | 322 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1998 | 298 | 0.010 |
Why?
|
| Base Sequence | 1 | 1998 | 932 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 1490 | 0.010 |
Why?
|
| Middle Aged | 1 | 2006 | 9642 | 0.010 |
Why?
|
| Brain | 1 | 1999 | 1268 | 0.010 |
Why?
|
| Adult | 1 | 2006 | 11034 | 0.010 |
Why?
|